Startseite Medizin National survey on delta checks in clinical laboratories in China
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

National survey on delta checks in clinical laboratories in China

  • Shukang He , Fengfeng Kang , Wei Wang , Bingquan Chen und Zhiguo Wang EMAIL logo
Veröffentlicht/Copyright: 13. Januar 2020
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background

This study aimed to understand the status quo of delta checks in Chinese clinical laboratories through a nationwide online survey.

Methods

The survey was divided into two parts. The first part was a general situation survey in which clinical laboratories had to provide information about the laboratories, including delta checks used. In the second part, clinical laboratories were asked to record the delta check alerts generated in their laboratories from June 1st, 2019 to June 30th, 2019.

Results

The most frequently used analytes in delta checks were potassium (K), glucose (Glu), creatinine (Cre) for clinical chemistry and hemoglobin (Hgb), platelet (PLT) count and white blood cell (WBC) count for clinical hematology. The median maximum time interval between specimens for all analytes was 5 days. The most commonly used delta check calculation modes in Chinese clinical laboratories were percentage change and absolute change. K and Hgb were the analytes most involved in clinical chemistry and clinical hematology delta check alerts. The most common causes of delta check alerts were that the patients had received treatment, which was followed by the change in the patient’s physiological state and interference from hemolysis, lipemia and icterus. The two most common outcomes of delta check alerts were ‘no problems found, standard report issued’ and ‘no problems found, report issued with comment’.

Conclusions

This study was the first nationwide survey of delta checks in China, the results of which help us to understand the current situation of delta checks in Chinese clinical laboratories.


Corresponding author: Prof. Zhiguo Wang, National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, No. 1, Dahua Road, Dongdan, Dongcheng District, Beijing 100730, P.R. China; and Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China, Tel.: +86-010-58115054, Fax: +86-010-65273025

Acknowledgments

We would like to extend our gratitude to the clinical laboratories in China that have taken part in our study and provided the relevant data that we needed. We are also deeply indebted to all the technical staff of the Clinet website (www.clinet.com.cn) for the technical support they provided.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: 1. National Natural Science Foundation of China (Funder Id: http://dx.doi.org/10.13039/ 501100001809, Grant No. 81871737). 2. Zhejiang Provincial Project for Medical and Health Science and Technology (Grant No. 2018KY009).

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Straseski JA, Strathmann FG. Patient data algorithms. Clin Lab Med 2013;33:147–60.10.1016/j.cll.2012.11.009Suche in Google Scholar PubMed

2. Randell EW, Yenice S. Delta checks in the clinical laboratory. Crit Rev Clin Lab Sci 2019;56:75–97.10.1080/10408363.2018.1540536Suche in Google Scholar PubMed

3. CLSI EP33. Use of delta checks in the medical laboratory. Wayne, PA, USA: Clinical and Laboratory Standards Institute, 2016. Suche in Google Scholar

4. Lenicek Krleza J, Honovic L, Vlasic Tanaskovic J, Podolar S, Rimac V, Jokic A. Post-analytical laboratory work: national recommendations from the Working Group for Post-analytics on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Biochem Med (Zagreb) 2019;29:020502.10.11613/BM.2019.020502Suche in Google Scholar PubMed PubMed Central

5. Lacher DA, Connelly DP. Rate and delta checks compared for selected chemistry tests. Clin Chem 1988;34:1966–70.10.1093/clinchem/34.10.1966Suche in Google Scholar

6. Kim JW, Kim JQ, Kim SI. Differential application of rate and delta check on selected clinical chemistry tests. J Korean Med Sci 1990;5:189–95.10.3346/jkms.1990.5.4.189Suche in Google Scholar PubMed PubMed Central

7. Iizuka Y, Kume H, Kitamura M. Multivariate delta check method for detecting specimen mix-up. Clin Chem 1982;28:2244–8.10.1093/clinchem/28.11.2244Suche in Google Scholar

8. Rosenbaum MW, Baron JM. Using machine learning-based multianalyte delta checks to detect wrong blood in tube errors. Am J Clin Pathol 2018;150:555–66.10.1093/ajcp/aqy085Suche in Google Scholar PubMed

9. Nosanchuk JS, Gottmann AW. CUMS and delta checks. A systematic approach to quality control. Am J Clin Pathol 1974;62:707–12.10.1093/ajcp/62.5.707Suche in Google Scholar PubMed

10. Schifman RB, Talbert M, Souers RJ. Delta check practices and outcomes: a q-probes study involving 49 health care facilities and 6541 delta check alerts. Arch Pathol Lab Med 2017;141:813–23.10.5858/arpa.2016-0161-CPSuche in Google Scholar PubMed

11. Strathmann FG, Baird GS, Hoffman NG. Simulations of delta check rule performance to detect specimen mislabeling using historical laboratory data. Clin Chim Acta 2011;412:1973–7.10.1016/j.cca.2011.07.007Suche in Google Scholar PubMed

12. Garner AE, Lewington AJ, Barth JH. Detection of patients with acute kidney injury by the clinical laboratory using rises in serum creatinine: comparison of proposed definitions and a laboratory delta check. Ann Clin Biochem 2012;49(Pt 1):59–62.10.1258/acb.2011.011125Suche in Google Scholar PubMed

13. Lippi G, Cadamuro J, Danese E, Gelati M, Montagnana M, von Meyer A, et al. Internal quality assurance of HIL indices on Roche Cobas c702. PLoS One 2018;13:e0200088.10.1371/journal.pone.0200088Suche in Google Scholar PubMed PubMed Central

14. Jones JB. A strategic informatics approach to autoverification. Clin Lab Med 2013;33:161–81.10.1016/j.cll.2012.11.004Suche in Google Scholar PubMed

15. Krasowski MD, Davis SR, Drees D, Morris C, Kulhavy J, Crone C, et al. Autoverification in a core clinical chemistry laboratory at an academic medical center. J Pathol Inform 2014;5:13.10.4103/2153-3539.129450Suche in Google Scholar PubMed PubMed Central

16. Park SH, Kim SY, Lee W, Chun S, Min WK. New decision criteria for selecting delta check methods based on the ratio of the delta difference to the width of the reference range can be generally applicable for each clinical chemistry test item. Ann Lab Med 2012;32:345–54.10.3343/alm.2012.32.5.345Suche in Google Scholar PubMed PubMed Central

17. Lee J, Kim SY, Kwon HJ, Lee HK, Kim Y, Kim Y. Usefulness of biological variation in the establishment of delta check limits. Clin Chim Acta 2016;463:18–21.10.1016/j.cca.2016.08.007Suche in Google Scholar PubMed

18. Ko DH, Park HI, Hyun J, Kim HS, Park MJ, Shin DH. Utility of reference change values for delta check limits. Am J Clin Pathol 2017;148:323–9.10.1093/ajcp/aqx083Suche in Google Scholar PubMed

19. Harris EK, Yasaka T. On the calculation of a “reference change” for comparing two consecutive measurements. Clin Chem 1983;29:25–30.10.1093/clinchem/29.1.25Suche in Google Scholar

20. Gruenberg JM, Stein TA, Karger AB. Determining the utility of creatinine delta checks: a large retrospective analysis. Clin Biochem 2018;53:139–42.10.1016/j.clinbiochem.2018.01.023Suche in Google Scholar PubMed

21. Ovens K, Naugler C. How useful are delta checks in the 21 century? A stochastic-dynamic model of specimen mix-up and detection. J Pathol Inform 2012;3:5.10.4103/2153-3539.93402Suche in Google Scholar PubMed PubMed Central

22. Karger AB. To delta check or not to delta check? That is the question. J Appl Lab Med 2017;1:457–9.10.1373/jalm.2016.022020Suche in Google Scholar PubMed

23. Rimac V, Lapic I, Kules K, Rogic D, Miler M. Implementation of the autovalidation algorithm for clinical chemistry testing in the laboratory information system. Lab Med 2018;49: 284–91.10.1093/labmed/lmx089Suche in Google Scholar PubMed

Received: 2019-10-10
Accepted: 2019-11-17
Published Online: 2020-01-13
Published in Print: 2020-03-26

©2020 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. New insights on the analytical performances for detecting and quantifying monoclonal proteins
  4. Reviews
  5. Vitamin C measurement in critical illness: challenges, methodologies and quality improvements
  6. Early predictors of perinatal brain damage: the role of neurobiomarkers
  7. Opinion Paper – Point
  8. Mixing studies for lupus anticoagulant: mostly yes, sometimes no
  9. Opinion Paper – Counterpoint
  10. Mixing studies for lupus anticoagulant: mostly no, sometimes yes
  11. EFLM Consensus Paper
  12. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
  13. Guidelines and Recommendations
  14. PREDICT: a checklist for preventing preanalytical diagnostic errors in clinical trials
  15. Genetics and Molecular Diagnostics
  16. Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction
  17. General Clinical Chemistry and Laboratory Medicine
  18. An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part I: factors impacting limit of quantitation of serum protein electrophoresis
  19. An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M-proteins
  20. Use of clinical data and acceleration profiles to validate pneumatic transportation systems
  21. National survey on delta checks in clinical laboratories in China
  22. Assessment of the glomerular filtration rate (GFR) in kidney transplant recipients using Bayesian estimation of the iohexol clearance
  23. Performance of Afinion HbA1c measurements in general practice as judged by external quality assurance data
  24. Renal tubular epithelial cells add value in the diagnosis of upper urinary tract pathology
  25. Reference Values and Biological Variations
  26. Influence of ethnicity on biochemical markers of health and disease in the CALIPER cohort of healthy children and adolescents
  27. Cardiovascular Diseases
  28. Clinical evaluation of capillary B-type natriuretic peptide testing
  29. Infectious Diseases
  30. Thrombo-inflammatory prognostic score improves qSOFA for risk stratification in patients with sepsis: a retrospective cohort study
  31. Corrigendum
  32. Corrigendum to: Pediatric reference intervals for 29 Ortho VITROS 5600 immunoassays using the CALIPER cohort of healthy children and adolescents
  33. Letters to the Editor
  34. Potential risks in fecal microbiota transplantation
  35. Macro-aspartate aminotransferase syndrome: a case report
  36. Factitious severe acidosis in a patient, preanalytical considerations and prevention
  37. Methods for quick, accurate and cost-effective determination of the type 1 diabetes genetic risk score (T1D-GRS)
  38. Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: two case reports
  39. Serum immunoglobulin-A (IgA) concentrations in a general adult population: association with demographics and prevalence of selective IgA deficiency
  40. Evaluation of PFA-100 closure times in cord blood samples of healthy term and preterm neonates
  41. Disagreement between direct and indirect potentiometric Na+ determination in infancy and childhood
  42. Carryover issues with UF-5000 urine flow cytometry – how did we miss it?
Heruntergeladen am 7.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2019-1131/html
Button zum nach oben scrollen